D J Vidyadhara - Related publications

Yale University School of Medicine, New Haven, CT 
Parkinson's disease, Neuroscience
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Zhu G, Wang W, Chen C, Tang L, Liang Y, Zhang Z, Lu Y, Zhao Y. UHPLC-MS-based metabolomics and chemoinformatics study reveals the neuroprotective effect and chemical characteristic in Parkinson's disease mice after oral administration of Wen-Shen-Yang-Gan decoction. Aging. 13. PMID 34339394 DOI: 10.18632/aging.203361   
2021 Rahul, Siddique Y. Neurodegenerative disorders and the current state, pathophysiology and management of Parkinson's disease. Cns & Neurological Disorders Drug Targets. PMID 34477534 DOI: 10.2174/1871527320666210903101841   
2021 Bastioli G, Regoni M, Cazzaniga F, De Luca CMG, Bistaffa E, Zanetti L, Moda F, Valtorta F, Sassone J. Animal Models of Autosomal Recessive Parkinsonism. Biomedicines. 9. PMID 34356877 DOI: 10.3390/biomedicines9070812   
2021 Yao L, Wu J, Koc S, Lu G. Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements. Frontiers in Cell and Developmental Biology. 9: 655819. PMID 34336822 DOI: 10.3389/fcell.2021.655819   
2021 Li Q, Shen C, Liu Z, Ma Y, Wang J, Dong H, Zhang X, Wang Z, Yu M, Ci L, Sun R, Shen R, Fei J, Huang F. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease. Cell Proliferation. e13094. PMID 34312932 DOI: 10.1111/cpr.13094   
2021 Lin TK, Lin KJ, Lin HY, Lin KL, Lan MY, Wang PW, Wang TJ, Wang FS, Tsai PC, Liou CW, Chuang JH. Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress. Frontiers in Molecular Neuroscience. 14: 697440. PMID 34305527 DOI: 10.3389/fnmol.2021.697440   
2021 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 12: 636139. PMID 34239490 DOI: 10.3389/fneur.2021.636139   
2021 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 12: 636139. PMID 34239490 DOI: 10.3389/fneur.2021.636139   
2021 Houser MC, Caudle WM, Chang J, Kannarkat GT, Yang Y, Kelly SD, Oliver D, Joers V, Shannon KM, Keshavarzian A, Tansey MG. Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathologica Communications. 9: 139. PMID 34412704 DOI: 10.1186/s40478-021-01240-4   
2021 Olubodun-Obadun TG, Ishola IO, Adeyemi OO. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease. Drug Metabolism and Personalized Therapy. PMID 34391219 DOI: 10.1515/dmdi-2021-0128   
2021 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Molecular Medicine Reports. 24. PMID 34414447 DOI: 10.3892/mmr.2021.12374   
2021 Ma X, Wang Q, Yuan W, Wang Y, Zhou F, Kang K, Tong X, Liu Z. Electroacupuncture Alleviates Neuroinflammation and Motor Dysfunction by Regulating Intestinal Barrier Function in a Mouse Model of Parkinson Disease. Journal of Neuropathology and Experimental Neurology. PMID 34343334 DOI: 10.1093/jnen/nlab046   
2021 Chen X, Cao W, Zhuang Y, Chen S, Li X. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease. Brain Research Bulletin. PMID 34536521 DOI: 10.1016/j.brainresbull.2021.09.010   
2021 Haque ME, Akther M, Azam S, Kim IS, Lin Y, Lee YH, Choi DK. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease. British Journal of Pharmacology. PMID 34528272 DOI: 10.1111/bph.15684   
2021 Leung D, Bonacorsi S, Smith RA, Weber W, Hayes W. Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic. Frontiers in Oncology. 11: 698425. PMID 34497758 DOI: 10.3389/fonc.2021.698425   
2021 Ciobanu AM, Ionita I, Buleandra M, David IG, Popa DE, Ciucu AA, Budisteanu M. Current advances in metabolomic studies on non-motor psychiatric manifestations of Parkinson's disease (Review). Experimental and Therapeutic Medicine. 22: 1010. PMID 34345292 DOI: 10.3892/etm.2021.10443   
2021 Taghizadeh E, Gheibihayat SM, Taheri F, Afshani SM, Farahani N, Saberi A. LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 34254198 DOI: 10.1007/s10072-021-05408-7   
2021 Sharma A, Müller J, Schuetze K, Rolfes V, Bissinger R, Rosero N, Ahmad A, Franklin BS, Zur B, Fröhlich H, Lang F, Oldenburg J, Pötzsch B, Wüllner U. Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease. Biology. 10. PMID 34439949 DOI: 10.3390/biology10080716   
2021 Deng I, Corrigan F, Garg S, Zhou XF, Bobrovskaya L. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice. International Journal of Molecular Sciences. 22. PMID 34299000 DOI: 10.3390/ijms22147380   
2021 Wang L, Sheng W, Tan Z, Ren Q, Wang R, Stoika R, Liu X, Liu K, Shang X, Jin M. Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments. Comparative Biochemistry and Physiology. Toxicology & Pharmacology : Cbp. 109151. PMID 34343700 DOI: 10.1016/j.cbpc.2021.109151   
2021 Zhao Y, Liu L, Weng L. Comparisons of Underlying Mechanisms, Clinical Efficacy and Safety Between Anti-PD-1 and Anti-PD-L1 Immunotherapy: The State-of-the-Art Review and Future Perspectives. Frontiers in Pharmacology. 12: 714483. PMID 34305619 DOI: 10.3389/fphar.2021.714483   
2021 Hu G, Wang D, Luo S, Hao Y, Nickerson LD, Cong F. Frequency specific co-activation pattern analysis via sparse nonnegative tensor decomposition. Journal of Neuroscience Methods. 109299. PMID 34339754 DOI: 10.1016/j.jneumeth.2021.109299   
2021 Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED, Gavioli EC. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451872 DOI: 10.3390/ph14080775   
2021 Bian LH, Yao ZW, Zhao CB, Li QY, Shi JL, Guo JY. Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor. Evidence-Based Complementary and Alternative Medicine : Ecam. 2021: 6686965. PMID 34426745 DOI: 10.1155/2021/6686965   
2021 Huang M, Lou D, Charli A, Kong D, Jin H, Zenitsky G, Anantharam V, Kanthasamy A, Wang Z, Kanthasamy AG. Mitochondrial dysfunction-induced H3K27 hyperacetylation perturbs enhancers in Parkinson's disease. Jci Insight. 6. PMID 34494552 DOI: 10.1172/jci.insight.138088   
2021 Wijesekara N, Ahrens R, Wu L, Langman T, Tandon A, Fraser PE. α-Synuclein Regulates Peripheral Insulin Secretion and Glucose Transport. Frontiers in Aging Neuroscience. 13: 665348. PMID 34393754 DOI: 10.3389/fnagi.2021.665348   
2021 Lyu Y, Huang Y, Shi G, Lei X, Li K, Zhou R, Bai L, Qin C. Transcriptome profiling of five brain regions in a 6-hydroxydopamine rat model of Parkinson's disease. Cns Neuroscience & Therapeutics. PMID 34347369 DOI: 10.1111/cns.13702   
2021 Mitkova Z, Kamusheva M, Kalpachka D, Ignatova D, Tachkov K, Petrova G. Review of medicine utilization for Parkinson's disease management: the Bulgarian perspective. Journal of Public Health Research. PMID 34351100 DOI: 10.4081/jphr.2021.2396   
2021 Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson's disease. Metabolic Brain Disease. PMID 34370175 DOI: 10.1007/s11011-021-00808-2   
2021 Maple-Grødem J, Paul KC, Dalen I, Ngo KJ, Wong D, Macleod AD, Counsell CE, Bäckström D, Forsgren L, Tysnes OB, Kusters CDJ, Fogel BL, Bronstein JM, Ritz B, Alves G. Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts. Journal of Parkinson's Disease. PMID 34275908 DOI: 10.3233/JPD-212657   
2021 Li S, Jia C, Li T, Le W. Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go. Neuroscience Bulletin. PMID 34313916 DOI: 10.1007/s12264-021-00749-x   
2021 Giuliano C, Francavilla M, Ongari G, Petese A, Ghezzi C, Rossini N, Blandini F, Cerri S. Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease. International Journal of Molecular Sciences. 22. PMID 34445626 DOI: 10.3390/ijms22168920   
2021 Pagano G, Molloy S, Bain PG, Rabiner EA, Ray Chaudhuri K, Brooks DJ, Pavese N. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [C]-PHNO PET study. Parkinsonism & Related Disorders. 90: 52-56. PMID 34385007 DOI: 10.1016/j.parkreldis.2021.06.025   
2021 Tamilanban T, Manasa K, Chitra V. In silico docking of Novel Phytoalkaloid Camalexin in the Management of Benomyl Induced Parkinson's disease and its In vivo Evaluation by Zebrafish Model. Cns & Neurological Disorders Drug Targets. PMID 34477539 DOI: 10.2174/1871527320666210903091447   
2021 Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, Martins OP, Piva HL, Felipe MSS, Amaral AC, Bocca AL, Tedesco AC, Mortari MR. Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease. Scientific Reports. 11: 15185. PMID 34312413 DOI: 10.1038/s41598-021-94175-8   
2021 Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, Martins OP, Piva HL, Felipe MSS, Amaral AC, Bocca AL, Tedesco AC, Mortari MR. Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease. Scientific Reports. 11: 15185. PMID 34312413 DOI: 10.1038/s41598-021-94175-8   
2021 Mahajan A, Marsili L, Dwivedi AK, Situ-Kcomt M, Grimberg MB, Wachter N, Abdelghany E, Duque KR, Espay AJ. Timing matters: Otological symptoms and Parkinson's disease. Parkinsonism & Related Disorders. 90: 23-26. PMID 34343875 DOI: 10.1016/j.parkreldis.2021.07.030   
2021 Maillet A, Météreau E, Tremblay L, Favre E, Klinger H, Lhommée E, Le Bars D, Castrioto A, Prange S, Sgambato V, Broussolle E, Krack P, Thobois S. Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34494685 DOI: 10.1002/mds.28722   
2021 Coates MD, Ba DM, Liu G, Dalessio S, Leslie DL, Huang X. Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease. Inflammatory Bowel Diseases. PMID 34259840 DOI: 10.1093/ibd/izab175   
2021 Vial F, Delgado I, Idiaquez JF, Canals F, Chana-Cuevas P. Epidemiology of Parkinson's Disease in Chile. Neuroepidemiology. 1-5. PMID 34407534 DOI: 10.1159/000517750   
2021 Lin Y, Xu D, Gao F, Zheng X. Ulinastatin inhibits NLRP3-induced apoptosis in a PD cell model. Annals of Translational Medicine. 9: 924. PMID 34350239 DOI: 10.21037/atm-21-1882   
2021 Cosentino G, Avenali M, Schindler A, Pizzorni N, Montomoli C, Abbruzzese G, Antonini A, Barbiera F, Benazzo M, Benarroch EE, Bertino G, Cereda E, Clavè P, Cortelli P, Eleopra R, et al. A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value. Journal of Neurology. PMID 34417870 DOI: 10.1007/s00415-021-10739-8   
2021 Landers MR, Jacobson KM, Matsunami NE, McCarl HE, Regis MT, Longhurst JK. A vicious cycle of fear of falling avoidance behavior in Parkinson's disease: A path analysis. Clinical Parkinsonism & Related Disorders. 4: 100089. PMID 34316667 DOI: 10.1016/j.prdoa.2021.100089   
2021 Ren X, Lin J, Stebbins GT, Goetz CG, Luo S. Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34327755 DOI: 10.1002/mds.28730   
2021 Zhao Z, Niu Y, Chen P, Zhu Y, Shi L, Zhao X, Wang C, Zhang Y, Gao Z, Jiang W, Ren W, Gu R, Yu Y. Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats. Neural Plasticity. 2021: 9938566. PMID 34367273 DOI: 10.1155/2021/9938566   
2021 Sinha S, Mittal S, Roy R. Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy. Journal of Movement Disorders. PMID 34315206 DOI: 10.14802/jmd.21046   
2021 Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota. Journal of Parkinson's Disease. PMID 34250955 DOI: 10.3233/JPD-212707   
2021 Li Z, Ren G, Liu C, Wang Q, Liang K, Han C, Qiao H, Zhang J, Wang Q, Meng F. Dysfunctional Brain Dynamics of Parkinson's Disease and the Effect of Acute Deep Brain Stimulation. Frontiers in Neuroscience. 15: 697909. PMID 34354564 DOI: 10.3389/fnins.2021.697909   
2021 Van Laar AD, Van Laar VS, San Sebastian W, Merola A, Bradley Elder J, Lonser RR, Bankiewicz KS. An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function. Journal of Parkinson's Disease. PMID 34366374 DOI: 10.3233/JPD-212724   
2021 Sakurai A, Tsunemi T, Ishiguro Y, Okuzumi A, Hatano T, Hattori N. Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. Journal of Neurology. PMID 34468800 DOI: 10.1007/s00415-021-10778-1